Caricamento...
ACTR-39. APPLICATION OF RTOG-RPA SCORES IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE (TTFIELDS/TMZ) VERSUS TEMOZOLOMIDE (TMZ) ALONE IN NEWLY DIAGNOSED GLIOBLASTOMA
BACKGROUND: A simplified model on prognostic factor recursive partitioning analysis (RPA) for survival of glioblastoma patients was previously published by the radiation therapy oncology group (RTOG) (Li et al. Int J Radiat Oncol Biol Phys. 2011). In this RPA model, patients are divided into three p...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692195/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.030 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|